AAAAAA

   
Results: 1-25 | 26-34
Results: 1-25/34

Authors: CANTILENA LR HONIG PK
Citation: Lr. Cantilena et Pk. Honig, QT DISPERSION AS A PREDICTOR OF PROARRHYTHMIA IN DRUG-INTERACTIONS WITH TERFENADINE, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 23-23

Authors: KIEFFER LV TAKIMOTO CH MORRISON GB CANTILENA LR ALLEGRA CJ GREM JL MARINO M
Citation: Lv. Kieffer et al., DEVELOPMENT OF A PHARMACOKINETIC AND PHARMACODYNAMIC POPULATION-MODELOF PACLITAXEL ADMINISTERED WITH 5-FLUOROURACIL, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 69-69

Authors: KATIAL RK STELZLE RC BONNER MW MARINO M CANTILENA LR SMITH LJ
Citation: Rk. Katial et al., A DRUG-INTERACTION BETWEEN ZAFIRLUKAST AND THEOPHYLLINE, Archives of internal medicine, 158(15), 1998, pp. 1713-1715

Authors: TAKIMOTO CH DAHUT W MARINO MT NAKASHIMA H LIANG MD HAROLD N LIEBERMAN R ARBUCK SG BAND RA CHEN AP HAMILTON JM CANTILENA LR ALLEGRA CJ GREM JL
Citation: Ch. Takimoto et al., PHARMACODYNAMICS AND PHARMACOKINETICS OF A 72-HOUR INFUSION OF 9-AMINOCAMPTOTHECIN IN ADULT CANCER-PATIENTS, Journal of clinical oncology, 15(4), 1997, pp. 1492-1501

Authors: GRAUMLICH JF LUDDEN TM CONRYCANTILENA C CANTILENA LR WANG YH LEVINE M
Citation: Jf. Graumlich et al., PHARMACOKINETIC MODEL OF ASCORBIC-ACID IN HEALTHY MALE-VOLUNTEERS DURING DEPLETION AND REPLETION, Pharmaceutical research, 14(9), 1997, pp. 1133-1139

Authors: SPYKER DA HARVEY ED HARVEY BE HARVEY AM RUMACK BH PECK CC ATKINSON AJ WOOSLEY RL ABERNETHY DR CANTILENA LR
Citation: Da. Spyker et al., ASSESSMENT OF CLINICAL-PHARMACOLOGY INFORMATION (CPI) IN DRUG LABELING, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 4-4

Authors: TAKIMOTO CH LU ZH ZHANG RW LIANG MD LARSON LV CANTILENA LR GREM JL ALLEGRA CJ DIASIO RB CHU E
Citation: Ch. Takimoto et al., SEVERE NEUROTOXICITY FOLLOWING 5-FLUOROURACIL-BASED CHEMOTHERAPY IN APATIENT WITH DIHYDROPYRIMIDINE DEHYDROGENASE-DEFICIENCY, Clinical cancer research, 2(3), 1996, pp. 477-481

Authors: HONIG PK WORTHAM DC LAZAREV A CANTILENA LR
Citation: Pk. Honig et al., GRAPEFRUIT JUICE ALTERS THE SYSTEMIC BIOAVAILABILITY AND CARDIAC REPOLARIZATION OF TERFENADINE IN POOR METABOLIZERS OF TERFENADINE, Journal of clinical pharmacology, 36(4), 1996, pp. 345-351

Authors: LEVINE M CONRYCANTILENA C WANG YH WELCH RW WASHKO PW DHARIWAL KR PARK JB LAZAREV A GRAUMLICH JF KING J CANTILENA LR
Citation: M. Levine et al., VITAMIN-C PHARMACOKINETICS IN HEALTHY-VOLUNTEERS - EVIDENCE FOR A RECOMMENDED DIETARY ALLOWANCE, Proceedings of the National Academy of Sciences of the United Statesof America, 93(8), 1996, pp. 3704-3709

Authors: CANTILENA LR WOOSLEY RL
Citation: Lr. Cantilena et Rl. Woosley, SURVEY OF CLINICAL-PHARMACOLOGY TRAINING IN THE UNITED-STATES AND CANADA, Clinical pharmacology and therapeutics, 60(1), 1996, pp. 1-7

Authors: BENTON RE HONIG PK ZAMANI K CANTILENA LR WOOSLEY RL
Citation: Re. Benton et al., GRAPEFRUIT JUICE ALTERS TERFENADINE PHARMACOKINETICS RESULTING IN PROLONGATION OF REPOLARIZATION ON THE ELECTROCARDIOGRAM, Clinical pharmacology and therapeutics, 59(4), 1996, pp. 383-388

Authors: COYNE PE AJAYI F HARRIS J WILEY T WORTHAM D CANTILENA LR
Citation: Pe. Coyne et al., ECG PHARMACODYNAMICS AND PHARMACOKINETICS OF HALOFANTRINE AND MEFLOQUINE, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 7-7

Authors: CANTILENA LR RATAIN MJ
Citation: Lr. Cantilena et Mj. Ratain, FOSTRIECIN NEPHROTOXICITY - AN IN-VITRO ASSESSMENT, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 8-8

Authors: CANTILENA LR WOOSLEY RL
Citation: Lr. Cantilena et Rl. Woosley, SURVEY OF CLINICAL-PHARMACOLOGY TRAINING IN NORTH-AMERICAN MEDICAL-SCHOOLS, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 96-96

Authors: FERGUSON CL CANTILENA LR
Citation: Cl. Ferguson et Lr. Cantilena, N-ACETYLCYSTEINE EFFECT ON MERCURY CLEARANCE DURING HEMODIALYSIS IN PIGS, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 110-110

Authors: KUANG TY CANTILENA LR
Citation: Ty. Kuang et Lr. Cantilena, EFFECT OF KETOCONAZOLE ON TERFENADINE ENANTIOMERIC METABOLISM IN HUMAN LIVER SLICES, MICROSOMES AND S9 FRACTIONS, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 185-185

Authors: KUANG TY CANTILENA LR
Citation: Ty. Kuang et Lr. Cantilena, TERFENADINE KETOCONAZOLE METABOLITE INTERACTION IN HUMAN LIVER-MICROSOMES OF MALE AND FEMALE SUBJECTS, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 185-185

Authors: HONIG P WORTHAM D LAZAREV A CANTILENA LR
Citation: P. Honig et al., PHARMACOKINETICS AND CARDIAC EFFECTS OF TERFENADINE IN POOR METABOLIZERS RECEIVING CONCOMITANT GRAPEFRUIT JUICE, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 185-185

Authors: CANTILENA LR SORRELS S WILEY T WORTHAM D
Citation: Lr. Cantilena et al., FLUCONAZOLE ALTERS TERFENADINE PHARMACOKINETICS AND ELECTROCARDIOGRAPHIC PHARMACODYNAMICS, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 185-185

Authors: SPYKER DA CANTILENA LR
Citation: Da. Spyker et Lr. Cantilena, CARDIOVASCULAR AND CNS ADVERSE EVENTS FOR ANTIDEPRESSANTS REPORTED TOTHE FDA, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 190-190

Authors: HOUGH DW FERGUSON CL WEINTRAUB M CANTILENA LR
Citation: Dw. Hough et al., AN ASSESSMENT OF CRITERIA FOR INAPPROPRIATE PRESCRIBING OF PSYCHOTROPIC MEDICATIONS IN THE ELDERLY, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 199-199

Authors: HOUGH DW SELLERS R CANTILENA LR
Citation: Dw. Hough et al., PANIC DISORDER IN A PATIENT TAKING OXAPROZIN, The American journal of psychiatry, 152(1), 1995, pp. 149-149

Authors: HONIG PK CANTILENA LR
Citation: Pk. Honig et Lr. Cantilena, POLYPHARMACY - PHARMACOKINETIC PERSPECTIVES, Clinical pharmacokinetics, 26(2), 1994, pp. 85-90

Authors: HONIG PK WORTHAM DC ZAMANI K CANTILENA LR
Citation: Pk. Honig et al., COMPARISON OF THE EFFECT OF THE MACROLIDE ANTIBIOTICS ERYTHROMYCIN, CLARITHROMYCIN AND AZITHROMYCIN ON TERFENADINE STEADY-STATE PHARMACOKINETICS AND ELECTROCARDIOGRAPHIC PARAMETERS, Drug investigation, 7(3), 1994, pp. 148-156

Authors: KUANG TY MORGAN A LAZAREV A CANTILENA LR
Citation: Ty. Kuang et al., COMPARISON OF HUMAN LIVER SLICES TO HUMAN LIVER-MICROSOMES AS POTENTIAL SCREENING SYSTEMS FOR TERFENADINE DRUG-INTERACTIONS, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 138-138
Risultati: 1-25 | 26-34